肿瘤浸润淋巴细胞是继LAK细胞之后研究的又一类新型抗瘤效应细胞。近几年,对肿瘤浸润淋巴细胞的免疫生物学及抗瘤活性进行了大量的研究,表明它具有特异高效的杀瘤效应等LAK 细胞所不能比拟的特点,并初步展示其临床应用的可行性和实用性,因此,肿瘤浸润淋巴细胞受到人们的广泛关注。 Tumor-infiltrating lymphocytes are another new type of anti-tumor effector cells that have been studied after LAK cells. In recent years, a large number of studies have been conducted on the immunobiology and anti-tumor activity of tumor-infiltrating lymphocytes, demonstrating that it has a specific and highly effective killing effect and LAK cells can not compare characteristics, and initially demonstrated its clinical feasibility And practicality, therefore, tumor infiltrating lymphocytes have attracted widespread attention.